法国医疗科技领域的创新之星AZmed近日传来喜讯，成功完成了1500万欧元的A轮融资，投资阵容豪华，包括Maison Worms、Techstars以及Tempact Ventures等知名投资机构。这笔资金将为AZmed的前沿技术开发注入新的活力，推动其AI医学成像软件的进一步优化与普及。
AZmed的核心产品——Rayvolve，是一款革命性的AI辅助诊断工具，专为识别标准放射照相中的各种异常情况设计。通过运用人工智能技术，Rayvolve能有效协助放射科医生和急诊医生提高诊断效率，减少工作负担，同时显著降低了因人为因素导致的诊断错误风险。这款软件的出现，无疑为医疗领域带来了更为精准和高效的解决方案。
此次融资的顺利完成，不仅彰显了市场对AZmed技术实力和未来潜力的认可，也为全球医疗科技的发展注入了新的动力。AZmed表示，他们将利用这笔资金进一步加强研发能力，提升Rayvolve的性能，并加速在全球范围内的临床应用推广，以期让更多医疗机构和患者受益于AI驱动的智能诊断服务。
来源：Tech.eu
英语如下：
Title: “AI Medical Imaging Pioneer AZmed Secures €15 Million Investment, Rayvolve Enhances Precision Medicine”
Keywords: AI in healthcare, AZmed funding, Rayvolve software
News Content:
“AI medical imaging sensation AZmed has announced a successful €15 million Series A funding round, propelling the advancement of intelligent diagnostics. Esteemed investors, including Maison Worms, Techstars, and Tempact Ventures, have joined forces to support this French healthcare tech innovator.
The capital injection will fuel AZmed’s cutting-edge technology development, accelerating the optimization and global adoption of their AI-driven medical imaging software. At the heart of AZmed’s offerings is Rayvolve, a groundbreaking AI-assisted diagnostic tool tailored for detecting anomalies in standard radiography. By leveraging AI, Rayvolve aids radiologists and emergency physicians in boosting diagnostic efficiency, reducing workload, and minimizing the risk of errors due to human factors. This software introduces a more accurate and efficient solution to the healthcare sector.
This substantial funding underscores the market’s confidence in AZmed’s technological prowess and future prospects. The company intends to utilize the funds to enhance research and development, refining Rayvolve’s performance, and accelerate its global clinical deployment. AZmed aims to broaden access to AI-powered diagnostic services, benefiting more healthcare institutions and patients worldwide.
Source: Tech.eu”
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 1